The shares of most publicly traded companies that rely primarily on patent licensing, litigation settlements or damages awards for revenue have fared poorly compared to

The shares of most publicly traded companies that rely primarily on patent licensing, litigation settlements or damages awards for revenue have fared poorly compared to
Publicly traded patent licensing companies have significantly under-performed market indexes. Only a few of the original listed stocks remain. The IP CloseUp 30, a feature